- Are we ready for conservative treatment in ovarian cancer?
-
Utrilla-Layna J, Zapardiel
- KMID: 2158806
- J Gynecol Oncol.
- 2015 Jan;26(1):75-76.
- doi: 10.3802/jgo.2015.26.1.75
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?
-
Helm CW
- KMID: 2158795
- J Gynecol Oncol.
- 2015 Jan;26(1):1-2.
- doi: 10.3802/jgo.2015.26.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Society of Gynecologic Oncology International Workshop 2014
-
Park JY, Ngan HY, Park W, Cao Z, Wu X, Ju W, Chung HH, Chang SJ, Park SY, Ryu SY, Kim JH, Cho CH, Lee KH, Lee JW, Kumarasamy S, Kim JW, Wilailak S, Kim BG, Kim DY, Konishi I, Lee JK, Wang KL, Nam JH
- KMID: 2158805
- J Gynecol Oncol.
- 2015 Jan;26(1):68-74.
- doi: 10.3802/jgo.2015.26.1.68
The Asian Society of Gynecologic Oncology International Workshop 2014 on gynecologic oncology was held in Asan Medical Center, Seoul, Korea on the 23rd to 24th August 2014. A total of... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria
-
Kong TW, Chang SJ, Paek J, Lee Y, Chun M, Ryu HS
- KMID: 2158800
- J Gynecol Oncol.
- 2015 Jan;26(1):32-39.
- doi: 10.3802/jgo.2015.26.1.32
OBJECTIVE: The purpose of this study is to validate the Gynecologic Oncology Group (GOG) criteria for adjuvant treatment in a different cohort of patients and to evaluate the simplified risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Single-site robotic surgery in gynecologic cancer: a pilot study
-
Yoo HN, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG
- KMID: 2158804
- J Gynecol Oncol.
- 2015 Jan;26(1):62-67.
- doi: 10.3802/jgo.2015.26.1.62
OBJECTIVE: To discuss the feasibility of single-site robotic surgery for benign gynecologic tumors and early stage gynecologic cancers. METHODS: In this single institution, prospective analysis, we analyzed six patients who had... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort
-
Endo D, Todo Y, Okamoto K, Minobe S, Kato H, Nishiyama
- KMID: 2158797
- J Gynecol Oncol.
- 2015 Jan;26(1):12-18.
- doi: 10.3802/jgo.2015.26.1.12
OBJECTIVE: Concurrent chemoradiotherapy (CCRT) is the primary treatment for locally advanced cervical cancer. We studied prognostic factors for patients treated with CCRT. METHODS: We retrospectively reviewed records of 85 consecutive patients... -
- CITED
-
- Close
- SHARE
-
- Close
- An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers
-
Vogel TJ, Knickerbocker A, Shah CA, Schiff MA, Isacson C, Garcia RL, Goff BA
- KMID: 2158799
- J Gynecol Oncol.
- 2015 Jan;26(1):25-31.
- doi: 10.3802/jgo.2015.26.1.25
OBJECTIVE: Despite the rarity of uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC), they contribute disproportionately to endometrial cancer deaths. Sufficient clinical information regarding treatment and prognosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study
-
Coccolini , Campanati , Catena F, Ceni V, Ceresoli M, Jimenez Cruz J, Lotti M, Magnone S, Napoli J, Rossetti D, De Iaco P, Frigerio L, Pinna A, Runnebaum , Ansaloni L
- KMID: 2158803
- J Gynecol Oncol.
- 2015 Jan;26(1):54-61.
- doi: 10.3802/jgo.2015.26.1.54
OBJECTIVE: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been recently reported with favorable oncological outcomes as treatment of advanced epithelial ovarian cancer (EOC). The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
-
Matsuo K, Mabuchi S, Okazawa M, Kawano M, Kuroda H, Kamiura S, Kimura T
- KMID: 2158796
- J Gynecol Oncol.
- 2015 Jan;26(1):3-11.
- doi: 10.3802/jgo.2015.26.1.3
OBJECTIVE: Presence of high-risk factor in cervical cancer is known to be associated with decreased survival outcomes. However, the significance of multiple high-risk factors in early-stage cervical cancer related to... -
- CITED
-
- Close
- SHARE
-
- Close
- The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
-
Mattes MD, Lee JC, Metzger DJ, Ashamalla , Katsoulakis E
- KMID: 2158798
- J Gynecol Oncol.
- 2015 Jan;26(1):19-24.
- doi: 10.3802/jgo.2015.26.1.19
OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node... -
- CITED
-
- Close
- SHARE
-
- Close
- DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
-
Kato M, Takano M, Miyamoto M, Sasaki N, Goto T, Tsuda H, Furuya K
- KMID: 2158801
- J Gynecol Oncol.
- 2015 Jan;26(1):40-45.
- doi: 10.3802/jgo.2015.26.1.40
OBJECTIVE: Recent investigations have revealed DNA mismatch repair (MMR) gene mutations are closely related with carcinogenesis of endometrial cancer; however the impact of MMR protein expression on prognosis is not... -
- CITED
-
- Close
- SHARE
-
- Close
- Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings
-
Wilailak S, Chan KK, Chen CA, Nam JH, Ochiai K, Aw TC, Sabaratnam S, Hebbar S, Sickan J, Schodin BA, Charakorn , Sumpaico W
- KMID: 2158802
- J Gynecol Oncol.
- 2015 Jan;26(1):46-53.
- doi: 10.3802/jgo.2015.26.1.46
OBJECTIVE: The purpose of this study was to develop a risk prediction score for distinguishing benign ovarian mass from malignant tumors using CA-125, human epididymis protein 4 (HE4), ultrasound findings,... -
- CITED
-
- Close
- SHARE
-
- Close
